IJGC Podcast

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Robert Soslow to talk about updates on endometrial cancer pathology. Rob Soslow has been the lead gynecologic pathologist at Memorial Sloan Kettering Cancer Center for nearly 20 years and has served on the executive committee of the International Society of Gynecological Pathologists, the council of the International Gynecologic Cancer Society and the editorial boards of several journals, including the International Journal for Gynecologic Cancer. He is an enthusiastic diagnostician, mentor, educator and investigator.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Igance Vergote to talk about HIPEC in advanced ovarian cancer. Professor Ignace Vergote is Chairman of the Department of Gynaecology and Obstetrics at the Catholic University Leuven since 2003. He published more than 900 papers on gynecologic cancer in peer-reviewed journals and his work was cited more than 50.000 times. He served as President of IGCS, ESGO, EORTC-GCG and ENGOT.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Nicole Fleming to talk about imaging and laparoscopy in assessment of advanced ovarian cancer. Dr. Fleming is an Associate Professor in the Department of Gynecologic Oncology at MD Anderson Cancer Center in Houston, Texas. She is the Chair of the Ovarian Cancer quality improvement committee for her department and has special research interests in surgical innovation in ovarian cancer.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Walter Gotlieb to talk about robotic surgery for interval cytoreduction in advanced ovarian cancer and his article, "Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy" (https://ijgc.bmj.com/content/early/2019/10/09/ijgc-2019-000413), which is the Lead Article for the November 2019 issue of the International Journal of Gynecological Cancer. Dr. Gotlieb is Professor & Chief of ObGyn at the McGill-affiliated Jewish General Hospital in Montreal. He is past President of GOC, the Gyn-Onc Society of Canada, past Secretary Treasurer of IGCS, and completed 10 years as senior editor of the IJGC.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Henrik Falconer from Karolinska University Hospital to talk about the RACC trial. Dr. Falconer is the Head of Gynecological Oncology at Karolinska University Hospital in Sweden and the Principal Investigator for the RACC trial.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Reitan Riberio from the Erasto Gertner Hospital in Brazil to talk about uterine transposition surgery.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Alexander Melamed from Columbia University to talk about health services research in gynecologic oncology. Dr. Melamed is an assistant professor in Columbia University’s Vagelos College of Physicians and Surgeons, and a gynecologic oncologist practicing at New York Presbyterian/Columbia University Irving Medical Center. His research seeks to improve cancer care by applying innovative study designs and analytic approaches to observational data.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Ester Miralpeix from Hospital Del Mar to talk about prehabilitation programs in gynecologic oncology and her article, ""Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program"" {https://ijgc.bmj.com/content/early/2019/08/30/ijgc-2019-000597), which is the Lead Article for the November 2019 issue of IJGC. Dr. Ester Miralpeix is currently working at Hospital del Mar, Barcelona as a gynecologist and as an Associate Professor at Universitat Autònoma de Barcelona. During her career, she has rotated in some leading cancer centers like University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Dr. Miralpeiz has always been heavily involved in gynecologic cancer and the development of innovative strategies for improving patient care trough ERAS and Prehabilitation programs."

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Amir Jazaeri from the MD Anderson Cancer Center to provide an introductory overview of the current state and future challenges for immunotherapy in gynecologic cancers. Dr. Jazaeri is a Professor and the Director of the Gynecologic Cancer Immunotherapy Program in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas, MD Anderson Cancer Center. Since his recruitment to MD Anderson in 2014, he has established a broad base immunotherapy program for gynecologic cancers that include adoptive cell therapies and immune checkpoint inhibitor investigations. His other areas of research interest include innovative clinical trial designs and translational research for identification of novel immunotherapy targets for gynecologic cancers.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Marie Plante to talk about the CONTESSA/NEOCON Trial and conservative management of cervical cancer. Dr. Plante has a major interest in minimally invasive surgical (MIS) approaches in the treatment of gynecologic cancers and in fertility-preserving surgery for young women with cervical cancer. Dr Plante is currently leading two important international trials the SHAPE trial and the Contessa trial and currently serves as the co-chair of the cervical cancer research network (CCRN) as part of the GCIG.